Dr. Hamid Salim Shaaban, MD

Dr. Shaaban practices at Saint Michael's Medical Center in Newark, New Jersey, part of Prime Healthcare Services.

Dr. Shaaban's NPI, 1578854618, was assigned on April 24, 2011. Dr. Shaaban holds New Jersey license 25MA089190000.

Dr. Shaaban's primary practice is Saint Michael's Medical Center, at 111 Central Avenue, Newark, NJ 07102 in Essex County. The practice phone is (973) 877-5350.

Dr. Shaaban's primary practice is Saint Michael's Medical Center in Newark, New Jersey, part of Prime Healthcare Services. The medical group on file is Central Avenue Professional Services. Dmand AI also links Dr. Shaaban to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shaaban practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Shaaban's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Shaaban is licensed in New Jersey.

CMS data shows 563 Medicare services from Dr. Shaaban across 9 procedure codes in 2024, for 185 Medicare patients. Medicare paid $43,504 for them.

CMS counts 185 Medicare patients who saw Dr. Shaaban in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shaaban's median patient age at 52, with 61% women.

In 2024, Dr. Shaaban wrote 703 Medicare Part D claims for 134 patients. 64% of them were for generic drugs. CMS names the drug for 448 of them, across 24 drugs with 11 or more claims each, at $1,469,969 in total drug cost. In 2023, CMS named 209 claims across 11 drugs.

Dr. Shaaban accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shaaban as offering telehealth.

Dmand AI links 83 papers to Dr. Shaaban, published from 2016 to 2025. 2021 was the busiest year, with 18. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Coronavirus Infections. Dr. Shaaban has published most often in Cureus. Dr. Shaaban's most frequent co-authors are Gunwant K. Guron, MD, Jihad Slim, MD and Yazan Abdeen, MD.

CMS Open Payments shows 215 general payments to Dr. Shaaban from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,605.